About Elligo Health Research

Elligo helps speed new therapies to market by enabling large numbers of patients and clinicians to participate in clinical research. Studies have shown that only a very small portion of eligible patients participate in clinical research, even though a majority say they are interested in doing so. We remove the logistical obstacles that prevent their participation. Our unique direct to patient model allows us to streamline patient identification and qualification, site activation, patient enrollment, study initiation and study conclusion. This results in more efficient and cost-effective trials and acceleration of new therapies to market.